An adMare Tx Accelerator company, NorthMiRs has won the first prize of $250K at ECHO PITCH 2024. It was one of the four selected startups in the cardiovascular sector to compete for this generous award and they created a great impact on the judges of the competition.
The Entrepreneurship for Cardiovascular Health Opportunities, also commonly known as ECHO, PITCH 2024, is a very reputable platform for those who want to showcase their innovation and has huge popularity among its audience of scientists, investors, clinicians, and entrepreneurs.
NorthMiRs is working on novel RNA-based therapeutics that have the capability to disrupt the healthcare and medical field and will help in the treatment of sepsis and related conditions. NM-001 is the primary product of the company that is used in the treatment of sepsis-induced cardiac dysfunction, which is a condition in which the heart’s functioning is disturbed due to an infection in the body.
Samantha McWhirter is the Co-founder and CEO of NorthMiRs, and she said that the funding will go towards the essential testing of their primary product.
Swastik Saraf is the Founder and Managing Editor of TheMedSector. With a background in data journalism and healthcare research, he specializes in aggregating public health metrics, analyzing institutional data, and mapping out regional healthcare infrastructure. Swastik leads the data compilation team at TheMedSector, ensuring all directory tracking is built on verified primary sources before undergoing formal clinical review.
